Exclusive: Northwest Bio suspends screening of patients in brain cancer trial

(Reuters) - The chief executive officer of biotechnology company Northwest Biotherapeutics Inc said on Friday the company has temporarily stopped screening new patients for the trial of its experimental brain cancer drug.